Trial
NCT02946580
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
AstraZeneca
Condition
Constipation
Intervention
MOVANTIK™ (naloxegol)
Why stopped
Slow recruitment and inability to extend funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-10